Menu Close

Summary*

KRY, founded in 2014 and headquartered in Stockholm, Sweden, is a digital healthcare provider offering a wide range of medical services through video calls, in-app chats, and physical healthcare centers. The company has experienced significant growth since its inception, raising a total of $730.99 million across multiple funding rounds. KRY's latest valuation, as of 2021, stood at $2 billion, demonstrating strong investor confidence in its business model and potential for expansion.

The company's innovative approach to healthcare delivery has positioned it as a leader in the telemedicine sector, with a focus on primary and urgent care, as well as consultations with various medical professionals. KRY's platform supports digital prescription renewals and appointment bookings, catering to a diverse patient base with multilingual support.

While there is currently no official information available regarding KRY's IPO prospects, the company's strong funding history and impressive valuation growth may indicate potential for a future public offering. However, it's important to note that any discussions about a possible IPO remain speculative at this time.

Factors that could influence KRY's decision to go public in the future may include market conditions, the company's financial performance, and its strategic growth plans. The ongoing evolution of the digital healthcare industry and increasing demand for telemedicine services could also play a role in shaping the company's long-term strategy.

Investors interested in the potential opportunity to buy KRY shares or invest in KRY stock should keep an eye on official announcements from the company regarding any plans for an initial public offering. As with any investment decision, it's crucial to conduct thorough research and consider the associated risks before making any financial commitments.

How to invest in KRY

While KRY's IPO prospects remain uncertain, investors interested in the digital healthcare sector don't have to wait on the sidelines. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides opportunities to invest in potential leaders in the telemedicine and digital health space, with lower minimum investments than traditional private equity channels. This allows you to potentially benefit from KRY's growth and innovation in the healthcare industry, even before it hits the public markets.

*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.